These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530 [TBL] [Abstract][Full Text] [Related]
27. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Flanagan EP; Hinson SR; Lennon VA; Fang B; Aksamit AJ; Morris PP; Basal E; Honorat JA; Alfugham NB; Linnoila JJ; Weinshenker BG; Pittock SJ; McKeon A Ann Neurol; 2017 Feb; 81(2):298-309. PubMed ID: 28120349 [TBL] [Abstract][Full Text] [Related]
28. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Golombek SJ; Graus F; Elkon KB Arthritis Rheum; 1986 Sep; 29(9):1090-7. PubMed ID: 3753538 [TBL] [Abstract][Full Text] [Related]
29. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome. Hellmich B; Ciaglo A; Schatz H; Coakley G Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585 [TBL] [Abstract][Full Text] [Related]
30. Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients. Liu T; Chen B; Yang H; Huang J; Liu S; Yang X; Huang L; Yao H; Qiu W; Zhuang H; Long Y; Gao C Mult Scler Relat Disord; 2019 Feb; 28():177-183. PubMed ID: 30611927 [TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients. Jarius S; Lechner C; Wendel EM; Baumann M; Breu M; Schimmel M; Karenfort M; Marina AD; Merkenschlager A; Thiels C; Blaschek A; Salandin M; Leiz S; Leypoldt F; Pschibul A; Hackenberg A; Hahn A; Syrbe S; Strautmanis J; Häusler M; Krieg P; Eisenkölbl A; Stoffels J; Eckenweiler M; Ayzenberg I; Haas J; Höftberger R; Kleiter I; Korporal-Kuhnke M; Ringelstein M; Ruprecht K; Siebert N; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; Rostásy K; J Neuroinflammation; 2020 Sep; 17(1):262. PubMed ID: 32883358 [TBL] [Abstract][Full Text] [Related]
32. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Hirohata S; Arinuma Y; Yanagida T; Yoshio T Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341 [TBL] [Abstract][Full Text] [Related]
33. Anti-MOG autoantibody-associated schizophreniform psychosis. von Zedtwitz K; Matteit I; Michel M; Feige B; Runge K; Denzel D; Schlump A; Nickel K; Schiele MA; Berger B; Prüss H; Urbach H; Domschke K; Tebartz van Elst L; Endres D Acta Neuropsychiatr; 2022 Feb; 34(1):47-54. PubMed ID: 34493350 [TBL] [Abstract][Full Text] [Related]
35. [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment]. Tebartz van Elst L; Bechter K; Prüss H; Hasan A; Steiner JH; Leypoldt F; Endres D Nervenarzt; 2019 Jul; 90(7):745-761. PubMed ID: 31197396 [TBL] [Abstract][Full Text] [Related]
36. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls. Melkersson K; Bensing S Neuro Endocrinol Lett; 2018 Mar; 39(1):33-42. PubMed ID: 29803205 [TBL] [Abstract][Full Text] [Related]